The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths
every year, corresponding to nearly 6% of all deaths globally. Therefore, the effective …

Chronic liver diseases often result in the development of liver fibrosis and ultimately,
cirrhosis. Treatment strategies and prognosis differ greatly depending on the severity of liver …

Alcoholic liver disease (ALD) is a leading cause of cirrhosis, liver cancer, and acute and
chronic liver failure and as such causes significant morbidity and mortality. While alcohol …

Objective Recent evidence suggests that alcoholic fatty liver disease (AFLD) and non-
alcoholic fatty liver disease (NAFLD) may differentially affect risk of cardiovascular mortality …

Non-alcoholic fatty liver disease (NAFLD) is the main cause of liver diseases in Spain and
the incidence is raising due to the outbreak of type 2 diabetes and obesity. This CPG …

Chronic hepatitis B virus (HBV) infection is a major cause of liver morbidity and mortality
worldwide. While a proportion of the 250 million individuals chronically infected with HBV …

METHODS: Leveraging data from the Global Burden of Disease Study 2019, we analyzed
the prevalence, mortality, and disability-adjusted life years of alcohol-associated cirrhosis …

Background No prognostic tools are established for alcohol‐related liver disease (ALD).
Collagen proportionate area (CPA) measurement is a technique that quantifies fibrous …

Background Non‐invasive assessment of fibrosis is predictive of the prognosis of non‐
alcoholic and alcoholic fatty liver disease but this has not been demonstrated in metabolic …

La enfermedad hepática grasa no alcohólica (EHGNA) es la causa más frecuente de
hepatopatía crónica en nuestro medio y se prevé un incremento de su incidencia en los …